Application of Artificial Intelligence in Targeting Retinal Diseases

Francesco Saverio Sorrentino1, Giuseppe Jurman2, Katia De Nadai3

  • 1Department of Surgical Sciences, Maggiore Hospital, Azienda USL Bologna, Bologna, Italy.

Current Drug Targets
|July 10, 2020
PubMed
Summary

Artificial intelligence (AI) enhances retinal imaging analysis for diseases like diabetic retinopathy and macular degeneration. AI aids early detection, diagnosis, and personalized treatment, optimizing care despite specialist shortages.

Related Concept Videos